Taimei Technology and IHiS (now Synapxe) will co-develop Ethics and Compliance Online System (ECOS) to serve two healthcare groups in Singapore. Singapore Health Services (SingHealth) and National Healthcare Group (NHG) are two out of the three healthcare groups in Singapore, providing high quality care to patients and ensuring that they are well supported as they journey from one care setting to another. The two healthcare groups consist of general hospitals, community hospitals, national specialty centers, and a network of polyclinics.
By adopting Taimei Technology’s clinical trial ethics review platform, the ECOS will significantly harmonize Singapore’s clinical trial ethics reviews to achieve digital transformation and to optimize review efficiency and enhance supervision.
Ethics reviews involve the rights, safety, and well-being of all patients, and is an indispensable part of any clinical trial. At the same time, this mutual cooperation will also foster a significant and global expansion of Taimei Technology’s cutting-edge innovations in digital clinical data management, clinical operations, and pharmacovigilance.
Mr Zhao Lu, Chairman and CEO of Taimei Technology, said,
“In the face of the wave of pharmaceutical innovation, digital technology is showing strong empowerment. Within a few months, followed by CSI Medical Research, Taimei Technology and IHiS have reached long-term strategic cooperation, which is not only a high recognition of the technical strength of Taimei Technology by overseas users but also a deep resonance of the common concept of both parties to empower clinical research with digital technology. Taimei Technology will always practice the corporate mission of “accelerating the accessibility of innovative drugs,” empowering the pharmaceutical industry with digital technology, and contribute by building the digital ecosystem for the life science industry, for the benefit of patients.”
IHiS is a multiple award-winning Healthcare IT Leader that digitizes, connects, and analyses Singapore’s health ecosystem. Its ultimate aim is to improve the Singapore population’s health and health administrations by integrating intelligent, highly resilient, and cost-effective technologies with processes and people.
Being proudly recognized as a TAFEP Human Capital Partner (HCP), IHIS is committed to growing their businesses and staying competitive by having progressive employment practices, and developing their human capital.
IHiS played a key role in helping all major public healthcare institutions become amongst the first in Asia Pacific to achieve HIMSS EMRAM Stage 6 and 7, international benchmarks for advanced technology used in patient care.
Transforming healthcare through smart technology, IHiS has garnered more than 80 awards for its innovations. It supports more than 50,000 healthcare users in Singapore’s health ecosystem through the application of clinical informatics, computer science, data science, mechatronics, standards based IT that enables information exchange and cross boundary workflows, analysis, and statistical machine learning techniques to discover insights.
Taimei Technology is one of the leading integrated digital platforms dedicated to clinical research with in-depth insights in drug R&D, pharmacovigilance, marketing, and sales. Our digital cooperation platform TrialOS integrates advanced AI, big data, cloud computing, and mobile internet technologies to provide innovative solutions to industry stakeholders across the full product life cycle.
Through digital technology solutions and innovative services, we empower new drug research and development, accelerate the process of new medicine launches for our customers, and improve business performance. Together, we will fulfill the vision of “accelerating the accessibility of innovative drugs” and benefiting patients.